Late bleeding and neurological sequelae after heartmate II left ventricular assist device: Risk factors from the prequel

Journal of the American College of Cardiology

Volumn 63, Issue 9, 2014, Pages 889-890

  Najjar, Samer S ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

bleeding; heart failure; HeartMate II; LVAD; stroke

Indexed keywords

BLEEDING; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CLINICAL EFFECTIVENESS; DEVICE INFECTION; EQUIPMENT DESIGN; GASTROINTESTINAL HEMORRHAGE; HEART RIGHT VENTRICLE FAILURE; HEART VENTRICLE FAILURE; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; NOTE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RISK ASSESSMENT; SURVIVAL RATE; THROMBOSIS; TREATMENT DURATION; TREATMENT INDICATION; ANTICOAGULATION; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); COMORBIDITY; FOLLOW UP; FUNCTIONAL STATUS; HEART HEMODYNAMICS; HEART TRANSPLANTATION; HEMATOCRIT; ISCHEMIC CARDIOMYOPATHY; MEDICAL DEVICE COMPLICATION; NEUROLOGIC DISEASE; PREOPERATIVE PERIOD; PUMP THROMBOSIS; RETROSPECTIVE STUDY; RISK FACTOR; THROMBOCYTE AGGREGATION INHIBITION; VON WILLEBRAND DISEASE;

BLEEDING; HEART FAILURE; HEARTMATE II; LVAD; STROKE;

FEMALE; HEART FAILURE; HEART-ASSIST DEVICES; HEMORRHAGE; HUMANS; MALE; STROKE;

EID: 84895511154     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.11.018     Document Type: Editorial

References (12)

1. E.A. Rose, A.C. Gelijns, A.J. Moskowitz for the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group Long-term use of a left ventricular assist device for end-stage heart failure N Engl J Med 345 2001 1435 1443
2. S.J. Park, C.A. Milano, A.J. Tatooles for the HeartMate II Clinical Investigators Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy Circ Heart Fail 5 2012 241 248
3. R. John, Y. Naka, and N.G. Smedira et al. Continuous flow left ventricular assist device outcomes in commercial use compared with the prior clinical trial Ann Thorac Surg 92 2011 1406 1413
4. J.G. Rogers, K.D. Aaronson, A.J. Boyle for the HeartMate II Investigators Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients J Am Coll Cardiol 55 2010 1826 1834
5. P.M. Eckman, and R. John Bleeding and thrombosis in patients with continuous-flow ventricular assist devices Circulation 125 2012 3038 3047
6. A.J. Boyle, U.P. Jorde, B. Sun for the HeartMate II Clinical Investigators Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMateII outpatients J Am Coll Cardiol 63 2014 880 888
7. L.W. Miller, F.D. Pagani, S.D. Russell for the HeartMate II Clinical Investigators Use of a continuous-flow device in patients awaiting heart transplantation N Engl J Med 357 2007 885 896
8. M.S. Slaughter, J.G. Rogers, C.A. Milano for the HeartMate II Investigators Advanced heart failure treated with continuous-flow left ventricular assist device N Engl J Med 361 2009 2241 2251
9. E.M. Hsich, D.C. Naftel, and S.L. Myers et al. Should women receive left ventricular assist device support?: findings from INTERMACS Circ Heart Fail 5 2012 234 240
10. T.S. Kato, P.C. Schulze, and J. Yang et al. Pre-operative and post-operative risk factors associated with neurologic complications in patients with advanced heart failure supported by a left ventricular assist device J Heart Lung Transplant 31 2012 1 8
11. R.C. Bogaev, S.V. Pamboukian, S.A. Moore for the HeartMate II Clinical Investigators Comparison of outcomes in women versus men using a continuous-flow left ventricular assist device as a bridge to transplantation J Heart Lung Transplant 30 2011 515 522
12. E. McGee, K.D. Aaronson, E.J. Birks for the ADVANCE Investigators An examination of survival by sex in the HVAD BTT and CAP trials Circulation 126 2012 A19611